Table 3 Most commonly prescribed drug groups with percentages of all prescriptions and estimated one-year prevalences of receiving at least one prescription

M01

Anti-inflammatory and antirheumatic products

15.9

33.2 [30.5–36.1]

41.1 [36.5–46.0]

35.3 [33.0–37.8]

J01

Antibacterials for systemic use

7.0

14.6 [12.7–16.7]

28.5 [24.5–33.1]

18.3 [16.5–20.3]

N02

Analgesics

6.3

14.0 [12.1–16.1]

25.0 [21.1–29.5]

17.1 [15.3–19.1]

A02

Drugs for acid related disorders

6.3

14.6 [12.6–16.8]

16.2 [13.2–19.8]

14.9 [13.3–16.7]

R05

Cough and cold preparations

5.7

7.2 [6.0–8.7]

14.2 [11.3–17.7]

9.1 [7.9–10.5]

R01

Nasal preparations

5.6

7.2 [5.9–8.9]

16.2 [13.2–19.8]

9.6 [8.3–11.1]

N06

Psychoanaleptics

4.6

3.8 [2.9–5.0]

7.8 [5.6–10.8]

4.9 [3.9–6.1]

N05

Psycholeptics

4.5

2.6 [1.8–3.6]

6.3 [4.3–9.2]

3.6 [2.8–4.7]

J04

Antimycobacterials

3.1

1.6 [1.0–2.5]

1.2 [0.6–2.5]

1.5 [1.0–2.2]

D07

Corticosteroids, dermatological preparations

3.1

7.0 [5.7–8.7]

10.8 [8.1–14.2]

8.1 [6.8–9.5]

J07

Vaccines

2.6

3.8 [2.8–5.2]

8.4 [6.0–11.7]

5.1 [4.1–6.4)